Rizzo, Alessandro
IRCCS Istituto Tumori Giovanni Paolo II,
Italy
2025 Rank: 3886
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 93 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3886 | 4071 |
| Total Cites | 2165 | 2291 |
| H-index | 23 | 23 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 64 | 67 |
| Number of Single+First Authored Papers | 139 | 139 |
| Total Cites to Single+First Authored Papers | 994 | 1029 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 1039 | 1078 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1101 | 1157 |
| Ratio of Total Citations to Distinct Citing Papers | 1.97 | 1.98 |
| Self-Citation Percentage |
5.50%
|
|
Rizzo, Alessandro
IRCCS Istituto Tumori Giovanni Paolo II,
Italy
2024 Rank: 5357
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 159 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5357 | 5841 |
| Total Cites | 1694 | 1792 |
| H-index | 21 | 21 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 35 | 35 |
| Number of Single+First Authored Papers | 134 | 134 |
| Total Cites to Single+First Authored Papers | 889 | 929 |
| Number of Single+First+Last Authored Papers | 140 | 140 |
| Total Cites to Single+First+Last Authored Papers | 894 | 934 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 942 | 978 |
| Ratio of Total Citations to Distinct Citing Papers | 1.80 | 1.83 |
| Self-Citation Percentage |
5.47%
|
|
Rizzo, Alessandro
IRCCS Istituto Tumori Giovanni Paolo II,
Italy
2023 Rank: 14299
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 526 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14299 | 10523 |
| Total Cites | 1166 | 1388 |
| H-index | 19 | 22 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 9 | 13 |
| Number of Single+First Authored Papers | 127 | 127 |
| Total Cites to Single+First Authored Papers | 726 | 874 |
| Number of Single+First+Last Authored Papers | 131 | 131 |
| Total Cites to Single+First+Last Authored Papers | 727 | 876 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 731 | 807 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.72 |
| Self-Citation Percentage |
15.99%
|
|
Rizzo, Alessandro
IRCCS Istituto Tumori Giovanni Paolo II,
Italy
2022 Rank: 106580
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4006 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106580 | 45425 |
| Total Cites | 399 | 694 |
| H-index | 11 | 16 |
| Hm-index | 4 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 3 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 220 | 398 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 220 | 399 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 319 | 381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.82 |
| Self-Citation Percentage |
42.51%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.